Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015)
Clinical trial NCT00163475 · COMPLETED
Trial details
- NCT number
- NCT00163475
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2005-08-01
- Enrollment
- 511
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.